6 days ago
NKTR
AnalystsSamantha SemenkowSamantha Semenkow's Stock Forecasts
AnalystsSamantha Semenkow
Sectors:
Analyst Ranking
Top 30%
#1539 out of 5263 analysts
Average Return
+2.52%
Win Rate
44%31 out of 71
Risk vs Reward
Poor
Good
Samantha Semenkow's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Bioage Labs IncBIOA | +181.82% | $6.05 | $17.05 | 2025-10-21 - 2026-04-24 | Strong Buy |
Bioage Labs IncBIOA | +122.01% | $7.68 | $17.05 | 2025-10-28 - 2026-04-24 | Strong Buy |
Roivant Sciences LtdROIV | +121.23% | $12.39 | $27.41 | 2025-09-01 - 2026-04-24 | Strong Buy |
Allogene Therapeutics IncALLO | +111.93% | $1.09 | $2.31 | 2025-05-14 - 2026-04-24 | Strong Buy |
Spyre Therapeutics IncSYRE | +110.74% | $33.06 | $69.67 | 2025-12-16 - 2026-04-24 | Strong Buy |
Samantha Semenkow Analyst Color
Get additional color on Samantha Semenkow's coverage of popular stocks
a month ago
NKTR
2 months ago
BIOA
2 months ago
CPRX
3 months ago
ROIV
2 years ago
CABA
2 years ago
EDIT
2 years ago
LRMR
Samantha Semenkow's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nektar TherapeuticsNKTR | 3 | Strong Buy | $151.00 | +64.70% | Maintains | 6 days ago |
Biohaven LtdBHVN | 3 | Strong Buy | $17.00 | +72.06% | Maintains | 25 days ago |
Beam Therapeutics IncBEAM | 4 | Strong Buy | $68.00 | +150.83% | Maintains | a month ago |
Rhythm Pharmaceuticals IncRYTM | 3 | Strong Buy | $142.00 | +65.69% | Maintains | a month ago |
Bioage Labs IncBIOA | 6 | Strong Buy | $52.00 | +204.99% | Maintains | 2 months ago |
Agios Pharmaceuticals IncAGIO | 2 | Strong Buy | $46.00 | +81.67% | Maintains | 2 months ago |
Catalyst Pharmaceuticals IncCPRX | 4 | Strong Buy | $35.00 | +27.88% | Maintains | 2 months ago |
Larimar Therapeutics IncLRMR | 7 | Strong Buy | $14.00 | +208.37% | Maintains | 2 months ago |
Cullinan Therapeutics IncCGEM | 1 | Strong Buy | $33.00 | +149.62% | Initiates Coverage On | 2 months ago |
Roivant Sciences LtdROIV | 4 | Strong Buy | $35.00 | +27.69% | Maintains | 3 months ago |
Argenx SeARGX | 8 | Strong Buy | $1,091.00 | +39.83% | Maintains | 4 months ago |
Amicus Therapeutics IncFOLD | 2 | Hold | $14.50 | +0.07% | Downgrades | 4 months ago |
Spyre Therapeutics IncSYRE | 1 | Strong Buy | $64.00 | -8.14% | Initiates Coverage On | 4 months ago |
Wave Life Sciences LtdWVE | 2 | Strong Buy | $30.00 | +317.83% | Maintains | 5 months ago |
Structure Therapeutics IncGPCR | 2 | Strong Buy | $100.00 | +119.83% | Maintains | 5 months ago |
Prime Medicine IncPRME | 5 | Hold | $4.25 | +14.86% | Maintains | 6 months ago |
Moonlake ImmunotherapeuticsMLTX | 3 | Strong Sell | $5.00 | -70.90% | Downgrades | 6 months ago |
Cabaletta Bio IncCABA | 4 | Strong Buy | $10.00 | +238.98% | Maintains | 8 months ago |
Allogene Therapeutics IncALLO | 3 | Strong Buy | $4.00 | +73.16% | Maintains | a year ago |
Acelyrin IncSLRN | 2 | Hold | $3.00 | N/A | Maintains | a year ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | a year ago |
Sana Biotechnology IncSANA | 2 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
Sensei Biotherapeutics IncSNSE | 2 | Strong Buy | $80.00 | N/A | Reinstates | 2 years ago |
Editas Medicine IncEDIT | 4 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
2seventy Bio IncTSVT | 2 | Strong Buy | $12.00 | N/A | Maintains | 2 years ago |
Morphic Holding IncMORF | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | 2 years ago |
Immunovant IncIMVT | 3 | Strong Buy | $50.00 | N/A | Maintains | 3 years ago |
9 Meters Biopharma IncNMTRQ | 3 | Hold | $0.75 | N/A | Maintains | 3 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.